References
- GutierrezRMBaezEGCardioactive agents from plantsMini Rev Med Chem20099787889919519512
- LoFHMakNKLeungKNStudies on the anti-tumor activities of the soy isoflavone daidzein on murine neuroblastoma cellsBiomed Pharmacother200761959159517905565
- MollerFJDielPZierauOHertrampfTMaassJVollmerGLong-term dietary isoflavone exposure enhances estrogen sensitivity of rat uterine responsiveness mediated through estrogen receptor alphaToxicol Lett2010196314215320381596
- AllredCDTwaddleNCAllredKFSoy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c miceJ Agric Food Chem200553228542855016248551
- JanningPSchuhmacherUSUpmeierAToxicokinetics of the phytoestrogen daidzein in female DA/Han ratsArch Toxicol200074842143011097378
- QiuFChenXYSongBZhongFLiuCXInfluence of dosage forms on pharmacokinetics of daidzein and its main metabolite daidzein-7-O-glucuronide in ratsActa Pharmacol Sin20052691145115216115384
- ZhengYLeeSOVerbruggenMAMurphyPAHendrichSThe apparent absorptions of isoflavone glucosides and aglucons are similar in women and are increased by rapid gut transit time and low fecal isoflavone degradationJ Nutr2004134102534253915465743
- LiXShenQYuanDMaAJiaWDetermination of daidzein in rat plasma by LCChromatographia2008683–4201205
- KullingSEHonigDMMetzlerMOxidative metabolism of the soy isoflavones daidzein and genistein in humans in vitro and in vivoJ Agric Food Chem20014963024303311410004
- ShenQLiXYuanDJiaWEnhanced oral bioavailability of daidzein by self-microemulsifying drug delivery systemChem Pharm Bull (Tokyo)201058563964320460789
- ZhangZHuangYGaoFBuHGuaWLiYDaidzein-phospholipid complex loaded lipid nanocarriers improved oral absorption: in vitro characteristics and in vivo behavior in ratsNanoscale2011341780178721350765
- ZhangZHuangYGaoFA self-assembled nanodelivery system enhances the oral bioavailability of daidzein: in vitro characteristics and in vivo performanceNanomedicine (Lond)2011681365137922026378
- GaoYGuWChenLXuZLiYThe role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseasesBiomaterials200829304129413618667234
- LavelleECSharifSThomasNWHollandJDavisSSThe importance of gastrointestinal uptake of particles in the design of oral delivery systemsAdv Drug Deliv Rev1995181522
- AgüerosMZabaletaVEspuelasSCampaneroMAIracheJMIncreased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticlesJ Control Release201014512820347897
- JainRAThe manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials200021232475249011055295
- PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev200355332934712628320
- ShiveMSAndersonJMBiodegradation and biocompatibility of PLA and PLGA microspheresAdv Drug Deliv Rev199728152410837562
- DamgeCAprahamianMMarchaisHBenoitJPPingetMIntestinal absorption of PLAGA microspheres in the ratJ Anat1996189Pt 34915018982822
- TewesFMunnierEAntoonBComparative study of doxorubicin- loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methodsEur J Pharm Biopharm200766348849217433641
- CuiFShiKZhangLTaoAKawashimaYBiodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluationJ Control Release2006114224225016859800
- CirpanliYBilensoyELale DoganAÇalisSComparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin deliveryEur J Pharm Biopharm2009731828919442723
- JefferyHDavisSSO’HaganDTThe preparation and characterisation of poly(lactide-co-glycolide) microparticles. I: oil-in-water emulsion solvent evaporationInt J Pharm1991772–3169175
- MuLFengSSA novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGSJ Control Release2003861334812490371
- FessiHPuisieuxFDevissaguetJPAmmouryNBenitaSNanocapsule formation by interfacial polymer deposition following solvent displacementInt J Pharm198955R14
- MolpeceresJGuzmanMAberturasMRChaconMBergesLApplication of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacementJ Pharm Sci19968522062138683450
- AdityaNPPatankarSMadhusudhanBMurthyRSSoutoEBArthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activityEur J Pharm Sci201040544845520493255
- AquilanoDCavalliRGascoMRSolid lipospheres obtained from hot microemulsions in the presence of different concentrations of cosurfactant: the crystallization of stearic acid polymorphsThermochim Acta19932302937
- HariharanSBhardwajVBalaISitterbergJBakowaskyURavi KumarMNDesign of estradiol loaded PLGA nanopaticles formulations: a potential oral delivery system for hormone therapyPharm Res200623118419516267632
- ArshadyRPreparation of biodegradable microspheres and microcapsules: 2. Polylactides and related polyestersJ Control Release1991171122
- LiXDengXYuanMInvestigation on process parameters involved in preparation of poly-DL-lactide–poly(ethylene glycol) microspheres containing Leptospira Interrogans antigensInt J Pharm1999178224525510205644
- ZhuKJJiangHLDuXYWangJXuWXLiuSFPreparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation techniqueJ Microencapsul200118224726011253941
- SahooSKPanyamJPrabhaSLabhasetwarVResidual polyvinyl alcohol associated with poly(D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptakeJ Control Release200282110511412106981
- AhlinPKristlJKristlAVrecerFInvestigation of polymeric nanoparticles as carriers of enalaprilat for oral administrationInt J Pharm20022391–211312012052696
- YinYChenDQiaoMWeiXHuHLectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistributionJ Control Release20071231273817728000
- HasanASSochaMLamprechtAEffect of the microencapsulation of nanoparticles on the reduction of burst releaseInt J Pharm20073441–2536117643878
- HurteauxREdwards-LevyFLaurent-MaquinDLevyMCCoating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptideEur J Pharm Sci2005242–318719715661490
- RatzingerGFillaferCKerletaVWirthMGaborFThe role of surface functionalization in the design of PLGA micro- and nanoparticiesCrit Rev Ther Drug Carrier Syst2010271183
- DelieFEvaluation of nano- and microparticle uptake by the gastrointestinal tractAdv Drug Deliv Rev1998342–322123310837679
- McCleanSProsserEMeehanEBinding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epitheliaEur J Pharm Sci1998621531639795038
- DongYFengSSPoly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsBiomaterials200526306068607615894372
- O’HaganDTJefferyHRobertsMJMcGeeJPDavisSSControlled release microparticles for vaccine developmentVaccine19919107687711759495
- HancockBCCarlsonGTLadipoDDLangdonBAMullarneyMPComparison of the mechanical properties of the crystalline and amorphous forms of a drug substanceInt J Pharm20022411738512086723
- CorriganDOHealyAMCorriganOIThe effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materialsInt J Pharm20032621–212513712927394
- FotiPErbaDSpadafrancaACiappellanoSBrescianiJTestolinGDaidzein is absorbed by passive transport in isolated small intestine of ratsNutr Res2006266284288
- FrickerGKrompTWendelAPhospholipids and lipid-based formulations in oral drug deliveryPharm Res20102781469148620411409
- LeighMvan HoogevestPTiemessenHOptimising the oral bioavailability of the poorly water-soluble drug cyclosporin A using membrane lipid technologyDrug Deliv Syst2001137377
- PorterCJTrevaskisNLCharmanWNLipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov20076323124817330072
- HamadaHIshiharaKMasuokaNMikuniKNakajimaNEnhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrinsJ Biosci Bioeng2006102436937117116587
- MadyFMAbou-TalebAEKhaledKAEvaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidineInt J Pharm20103971–21820600734
- MaitiKMukherjeeKGantaitASahaBPMukherjeePKCurcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in ratsInt J Pharm20073301–215516317112692
- Sachs-BarrableKLeeSDWasanEKThorntonSJWasanKMEnhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infectionsAdv Drug Deliv Rev200860669270118053611
- WinKYFengSSEffects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials200526152713272215585275
- FlorenceATHilleryAMHusainNJaniPUNanoparticles as carriers for oral peptide absorption: studies on particle uptake and fateJ Control Release1995361–23946